Challenging business models is the fourth paper in the pharma 2020 series on the future of the pharmaceutical industry to be published by pricewaterhousecoopers. It also provides leaders with key questions and actions to consider in the year ahead. The fundamental challenges on the romanian pharmaceutical market are another key objective of our paper. We beiel ve that at least three new, stronger forces wl eli merge that wl gli reatly alter the healthcare landscape. Technology is increasingly a strategic topic for biopharma leaders, as digital and data analytics are exploited for competitive advantage. In other words, what will the future of pharmaceutical marketing look like as we enter the new year. What impact will this evolution have on pharmaceutical sales jobs. Brimming with inspirational content, the latest marketing and sales trends, and actionable strategies to leverage digital opportunities so you can deliver a topnotch patient experience, future pharma is the eyes and ears of pharma commercialization. The pharmaceutical industry and the future of drug development. The report is furnished to the recipient for information purposes only. The future for pharma marketing is personal pharmaphorum. Welcome to the deloitte centre for health solutions report pharma and the connected patient. Pharmas fully integrated business model is under huge pressure and by 2020 no pharma company will be able to profit alone.
Regeneron has shared high hopes for its two candidates in the fight against covid19 on the first day of the fourday eyeforpharma. These changes mean any future product needs to have a market access strategy built into it during its initial stages of development. Jan 01, 2016 there are many problems facing the pharma business when it comes to marketing. These compounds are typically aggregators, reactive compounds andor panassay interference compounds pains, and many of them are frequent hitters. The pharmaceutical sector is no exception, even though companies are in the early. Marketing the future, the third in a series of papers on the future of the pharmaceutical industry published by pricewaterhousecoopers. In 1985 the ten largest firms accounted for about 20 percent of worldwide sales, whereas in 2002 the ten largest firms accounted for 48 percent of sales. Our predictions lean more towards an optimistic view of the future.
Build marketing and sales functions that are fit for the future. The future success of todays market leaders will be determined by how they react to these changes. The threshold of innovation in 2010, the pharmaceutical industry pharma will not only make white powders. Recent trends in specialty pharma business model sciencedirect. With new regulations, a growing care team, and aggressive merger and acquisition strategies, the pharmaceutical industry looks radically different than it did a few years ago, and the evolution is set to continue. With marketing a consistent issue for pharma, one which will likely continue to grow, getting personal is the only option for future success.
The changing landscape of physician interactions pharma. It will become a means of market differentiation and source of economic value. Propelling access and acceptance, realising true potential vikas bhadoria ankur bhajanka kaustubh chakraborty palash mitra. Creating the workforce of the future april 2020 reskilling employees to address talent gaps can help a company retain the bulk of its operations workers and empower them to take. Ftc delays novartis sandoz deal with aurobindo into 2020. The future of pharma marketing one to five years out. Many new opportunities existfrom screening potential research targets and using big data. Pharma automation markets 2020 development of pharma automation hardware, software and services markets until 2020 compound annual world market growth rates of automation products and services for the pharmaceutical industry. Aug 22, 2017 home the future of pharma marketing one to five years out posted august 22, 2017 in whitepapers with the monumental shifts in healthcare and the pharmaceutical industry expected to come from washington, d. Powerful forces are transforming healthcare from a providerdriven marketplace to a patientcentric health ecosystem. With solutions that have been used by providers for more than 25 years, merge healthcare, now part of ibm watson health, is a leading provider of medical imaging and information management software and. Pharma medical affairs 2020 and beyond matthias evers edd flemngi arnab ghatak jan hartmann arf nai thoo ron piervincenzi. Extract from the pricewaterhousecoopers report pharma 2020.
Digital transformation for biotech and pharma companies bcg. By preparing for this future now, organizations not only reduce. Pharma news, views and analysis of healthcare in a rapidly changing world. In this generation more pharmaceutical companies are using social media sites or. Each recipient should conduct its own investigation and analysis of. Pharmaceutical and life sciences advisory services leader at pricewaterhousecoopers.
What trends do you currently see in pharmaceutical marketing that will impact the way marketers reach patients, physicians and other stakeholders in. Trends for marketing in 2020 future marketing strategy. A glimpse into the future marketers are expected to take full control of the customer experience in the coming years the economist intelligence unit asked 499 one cant help but. Big pharma continues to go through some big changes. Has direct to consumer marketing in pharma had its day. Preparing for biopharma marketing in 2020 and beyond who is. Publicis sam welch on global shifts in the industry the changes within the pharmaceutical industry show no signs of abating as financial pressures whether from the decline of the traditional blockbuster or the rise of costcontainment measures.
With the monumental shifts in healthcare and the pharmaceutical industry expected to come from washington, d. Jul 17, 2012 in the future, marketing strategy will be heavily influenced by new trends for marketing here. The future of pharma marketing one to five years out pm360. However, neither the report, nor the project as a whole would have been possible to do without the. February 2020 pharma and medtech companies around the world. Digital technology is enabling new biopharma value propositions. Preparing for biopharma marketing in 2020 and beyond who is the marketer of the future.
Marketing the future is the third in this series of papers on the future of the pharmaceutical industry published by. Excipients spi pharma, one of our road to cphi milano sponsors discuss how they are preparing to face the future of. This connectivity is both within and beyond company walls. Marketing the future is the third in this series of papers on the future of the pharmaceutical industry published by pricewaterhousecoopers. Pharma 2020 marketing the future information packaging. Tisha oehmen july 17, 2012 6 comments its hard as marketers to get far enough out of the day to day to observe trends materializing to influence our ability to do our jobs, much less think about marketing in 2020. Publicis sam welch on global shifts in the industry the changes within the pharmaceutical industry show no signs of abating as financial pressures whether from the decline of the traditional blockbuster or the rise of costcontainment measures press down on companies. In this changing environment, we can observe four distinct strategic archetypes emerging. The pharmaceuticalbiotechnology industry has become increasingly concentrated over the past two decades. To gain insight, pm360 asked 12 experts the following questions. The primarycare sector is expanding and becoming more regimented, as. We built a model to estimate market growth, considering four demand drivers. Preparing for biopharma marketing in 2020 and beyond who.
A recent report puts forward two business models that are likely to emerge as companies prepare for this future. Pdf mergers and acquisitions in indian pharmaceutical. Strategies to improve interactions with key physicians. Propelling access and acceptance, realising true potential. Pfizer has already started to apply its commercial optimizer model in specialty businesses. Originators, the classical pharma model, focus on financing the development and marketing of new drugs. The major pharma companies rightly promote themselves as being researchbased. The future healthcare and pharma companies, especially larger ones, will focus on the. Supplying the future 1 table of contents introduction 2 the times they are achangin 3 new product types live licensing the increasing emphasis on outcomes.
Pdf mergers and acquisitions in indian pharmaceutical industry. The report draws on the detailed and incisive insights of 7 marketing professionals working in. Mar 28, 2019 assay interference caused by small molecules continues to pose significant challenges for early drug discovery. The 2020 deloitte global life sciences outlook takes a detailed look at the factors driving these changes and outlines suggestions on how biopharma and medtech organizations can aspire to find real value for themselves and their shareholders in the coming year. Pharma automation markets 2020 intechno consulting. The definition of value will be much broader and will expand as the types of healthcare stakeholders who demand a demonstration of value increase. Create organisational cultures that are suitable for marketing specialist healthcare packages. Dramatic changes the social, demographic and economic context in which the pharmaceutical industry pharma operates is changing dramatically. In a dissenting statement pdf, commissioner rohit chopra, a known consumer advocate, challenged the. In order to make the most of these future growth opportunities, the industry must fundamentally change the way. The pharma industry is no longer being rewarded for incremental innovation, metoo products and selling the most pills. There are many problems facing the pharma business when it comes to marketing. Innovations through mergers and acquisitions in the pharmaceutical sector.
This publication highlights how pharma s fully integrated business models may not be the best option for the. Pdf this case study focuses on the giant glaxo wellcome and smithkline beecham. The pharma supply chain needs a radical overhaul, and pwc predicts that it will undergo three key changes over the next decade. Pdf innovative strategy for the pharma of the future. Drivers of change analyses the operational challenges marketers face and examines solutions that will underpin solid, integrated marketing strategies. As author of the report, i take full responsibility for it, including any mistakes.
Products practice undertook a research project to examine the future of the indian pharmaceuticals market over the next decade. Excipients spi pharma, one of our road to cphi milano sponsors discuss how they are preparing to face the future of healthcare. Pharma operates in a constantly evolving landscape yet many companies persist with skillscompetency surveys of their people and processes which define their capability level in terms of the last 12 months to today. Healthcare and life sciences predictions 2020 a bold future. In this generation more pharmaceutical companies are using social media sites or ecommerce sites as a medium for. Nov 23, 2017 with marketing a consistent issue for pharma, one which will likely continue to grow, getting personal is the only option for future success. Creating a marketing and sales function that is fit for the future. The future of highly compliant, efficient equipment. In the future, leading the way with a multidimensional, patientcentric approach to the drug pipeline will allow for increased profits and improved health outcomes. Our contract services directory contains listings for all of your outsourcing needs, covering manufacturing, packaging, formulation, clinical trials, equipment, ingredients and more. In addition, healthcare and pharma companies are 9% more likely than their peers in other sectors to say that datadriven marketing is a topthree strategic priority in 2017.
India pharma 2020 propelling access and acceptance, realising true potential. Assay interference caused by small molecules continues to pose significant challenges for early drug discovery. Pdf the urge to merge in the pharmaceutical industry. Generic drug providers excel in producing and delivering drugs at a low cost and as a result are fully backward integrated. Anon, pharma 2020, the vision, pricewaterhousecoopers report, 2010. The future healthcare and pharma companies, especially larger. It will fragment, with different models for different product types and patient segments. We offer a unique and curated agenda that balances the most relevant marketing and sales content. Investment in data capabilities is set to increase for many of them. Pharma companies face a number of key decisions that will determine their success and even survival in a. With solutions that have been used by providers for more than 25 years, merge healthcare, now part of ibm watson health, is a leading provider of medical imaging and information management software and services. Contract pharma pharmaceutical and biopharmaceutical. This paper explores how the industrys approach to sales and marketing will change as it moves towards providing products and service to improve the health of patients, whilst clearly demonstrating value for money. Mergers and acquisitions in the pharmaceutical industry.
Mckinsey recently spoke to industry leaders in oncology research and cancer care to ask about their vision of the future for oncology. The report draws on the detailed and incisive insights of 7 marketing professionals working in leading companies in europe and the us. Research has shown that pharma mergers reduce innovation. Nov 11, 2019 20 stocks that could double your money in 2020 big gains could be just a click of the buy button away. How digital technology is enabling patient centricity. The future of pharma marketing one to five years out posted august 22, 2017 in whitepapers with the monumental shifts in healthcare and the pharmaceutical industry expected to come from washington, d. By 2020 the current role of the pharmaceutical industrys sales and marketing workforce will be replaced by a new model as the industry shifts from a massmarket to a targetmarket approach to increase revenue.
1490 1376 347 1306 725 409 322 618 840 1361 256 445 576 897 1007 262 433 311 16 160 712 673 612 247 1154 39 719 149 996 1527 1392 10 1270 747 468 446 608 79 59 413 1426 1170